Back to all MindMaze Therapeutics Holding SA press releases

MindMaze Therapeutics Holding SA

  • OTCQB:MMTZF
  • SIX:MMTX

MindMaze and Vibra Sign Term Sheet for Planned U.S. Go-to-Market Partnership

Published

Get alerts

Plain English summaries when MindMaze Therapeutics Holding SA announces news.

At a glance

Company
MindMaze Therapeutics Holding SA
Listings
OTCQB:MMTZF, SIX:MMTX
Announcement type
Corporate update
Published
Source announcement
eqs-news.com

FAQSIR Generated from this announcement View original release below for safe harbor and regulatory notices

Announcement Summary

MindMaze Therapeutics (SIX: MMTX) and Vibra Healthcare announced a structured go-to-market partnership in the United States.

  • The partnership is intended to expand use of MindMaze Therapeutics’ products and services across U.S. healthcare providers and settings.
  • The collaboration targets providers in inpatient hospitals, rehabilitation facilities, long-term acute care hospitals, skilled nursing facilities, outpatient rehabilitation facilities, and home care settings.
  • The companies said Vibra Healthcare’s extensive network, clinical expertise, and market access will support identification, introduction, and commercialization across the United States.
  • Planned activities include market promotion, real-world evidence, reimbursement strategies using existing codes, and addressing shortages of physical therapists, occupational therapists, and neurologists.

The companies signed a term sheet for the planned collaboration, are progressing toward a definitive agreement, and have commenced initial joint market-development activities.

Investor FAQs

MindMaze Therapeutics announced a structured go-to-market partnership with Vibra Healthcare in the United States. The collaboration is intended to expand the commercial footprint and use of MindMaze Therapeutics’ products and services across U.S. healthcare providers.

Source announcement

Company
MindMaze Therapeutics Holding SA
Title
MindMaze Therapeutics and Vibra Healthcare Announce Go-to-Market Partnership to Expand Commercial Footprint of Precision Neurotherapeutics in the U.S.
Published
Source site
eqs-news.com

Read the source announcement on eqs-news.com

FAQSIR's summary and investor FAQs are generated by AI from the text of this announcement alone, without information from other sources.

Figures, forecasts and other claims are the announcement's, not FAQSIR's. FAQSIR does not independently verify them.

Read the original press release

Full text as published, unedited.

Loading the original release…